Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo and tamsulosin-controlled, parallel design,
multinational study to evaluate the efficacy and safety of Tadalafil once-a-day dosing for 12
weeks in Asian men with signs and symptoms of benign prostatic hyperplasia (BPH).